Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
20 sept. 2022 05h18 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
Rich Insights into the Glaucoma Clinical Trial Analysis Featuring 70+ Companies and Therapies | DelveInsight
12 sept. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rich Insights into the Glaucoma Clinical Trial Analysis Featuring 70+ Companies and Therapies | DelveInsight The number of clinical trials in...
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
30 août 2022 09h01 HE
|
Eyenovia
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, brings...
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
30 août 2022 08h00 HE
|
Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
Optometry Equipment Market Report 2022: Rising Government Initiatives to Control Visual Impairment Fueling Growth
30 août 2022 05h18 HE
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamps, Wavefront Analyzer), Application(General Examination,...
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy
23 août 2022 08h03 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma
16 août 2022 08h01 HE
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
Outlook on the Minimally Invasive Glaucoma Surgery Devices Global Market to 2027 - Rapid Transition from Glaucoma Medications to Minimally Invasive Glaucoma Surgeries Presents Opportunities
22 juil. 2022 05h03 HE
|
Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2022-2027) by Target, Surgery, Product, End User, Geography, Competitive Analysis,...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
08 juin 2022 07h00 HE
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
08 juin 2022 02h00 HE
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...